Nucyreta 150mg Tablet ER
Marketer
Taj Pharma India Ltd
Salt Composition
Tapentadol (150mg)
Overview Nucyreta 150mg Tablet ER
Avelox 150mg extended-release tablets provide potent relief from moderate to severe acute pain in adults. This medication addresses a range of conditions including headaches, fever, menstrual cramps, dental pain, and the discomfort associated with colds. It offers effective pain management when other treatments prove insufficient. Dosage and treatment duration for Avelox 150mg extended-release tablets must be determined by your physician. This medication carries a significant risk of dependence. Common adverse effects include nausea, somnolence, vomiting, and vertigo. Patients with pre-existing cardiac, hepatic, or renal conditions should inform their doctor. Pregnant women, those intending to become pregnant, and breastfeeding mothers should seek medical advice before use.
Uses of Nucyreta 150mg Tablet ER
Significant to intense pain
Major Benefits of Nucyreta 150mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 150mg extended-release Nucyreta tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent daily timing is recommended.
Common Side effects of Nucyreta 150mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Sleepiness
How to use Nucyreta 150mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Nucyreta 150mg Extended-Release Tablets. Ingest the tablet whole; do not fracture, crush, or chew. While you can take it with or without food, consistency is key—maintain a regular daily schedule.
How Nucyreta 150mg Tablet ER works:
Extended-release Nucyreta 150mg tablets reduce pain sensation by inhibiting nerve signals to the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Nucyreta 150mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Nucyreta 150mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Nucyreta 150mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Nucyreta 150mg tablets can induce adverse reactions that impair driving ability. Refrain from operating a vehicle if you experience drowsiness, dizziness, visual disturbances, or slowed reflexes while using this medication.
KidneyCAUTION
Extended-release Nucyreta 150mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Nucyreta 150mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Nucyreta 150mg tablets require careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Nucyreta 150mg extended-release tablets are contraindicated in patients exhibiting severe renal dysfunction.
What if you forget to take Nucyreta 150mg Tablet ER :
Omit any missed Nucyreta 150mg Extended-Release Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Nucyreta 150mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Phenylpropanoid |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently